VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.32% | -41.14% | |||
| Depreciation & Amortization | -- | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | -40.38% | |||
| Operating Income | 6.30% | 40.38% | |||
| Income Before Tax | 6.99% | 39.94% | |||
| Income Tax Expenses | -- | -100.00% | |||
| Earnings from Continuing Operations | 6.99% | 42.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.99% | 42.81% | |||
| EBIT | 6.30% | 40.38% | |||
| EBITDA | 6.38% | 41.14% | |||
| EPS Basic | 0.00% | 42.86% | |||
| Normalized Basic EPS | 0.00% | 50.00% | |||
| EPS Diluted | 0.00% | 42.86% | |||
| Normalized Diluted EPS | 0.00% | 50.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||